Archive

December 31, 2025

Browsing

This year brought us Trump the Sequel and that meant the left had extra motivation to be annoying. Their hatred of President Donald Trump, conservatives and even the late Charlie Kirk defined 2025.

Still, there were some who outdid everyone else in their quest to be, drumroll, please, the Most Annoying Person of 2025. I ignored people who made news saying just one idiotic comment or who are just obscure media personalities. (Like Matthew Dowd who lost his bogus MSNBC job for his comments bashing Turning Point USA founder Charlie Kirk for ‘hate speech’ after Kirk had been murdered.)

1. He was funny 20 years ago

No one deserves the top spot on this list more than ‘Jimmy Kimmel Live!’ host Jimmy Kimmel. Most late-night programs have faded from view as their hosts have turned them into orgies of Trump-bashing. But Kimmel excels at hating conservatives so much that he almost qualifies to be a male cast member of ‘The View.’ (Yep, they’re here, too.)

Kimmel gained more attention for saying vile things and fighting Trump than for anything funny.

Former ‘Late Show’ host David Letterman termed Kimmel, ‘the leader of the resistance,’ and Kimmel later cried millionaire tears because he had a ‘hard year.’ He earned a temporary suspension with one of the worst comments about the Kirk assassination, saying, ‘We hit some new lows over the weekend, with the MAGA gang desperately trying to characterize this kid who murdered Charlie Kirk as anything other than one of them and everything they can to score political points from it.’ He was wrong, of course, but we are used to that. Trump later said, ‘Jimmy Kimmel was horrible,’ and who am I to disagree with my president?

2. You knew they’d make the list

If the annoying people of Earth have a home base, it’s not some secluded island fortress, it’s ABC’s ‘The View.’ The gaggle of hosts — from leftist moderator Whoopi Goldberg to crackpot Joy Behar to pretend conservative Alyssa Farah Griffin — is a reminder that quantity is not quality. 

This year, they pretended radical Islamic Iran wasn’t worse than the U.S. (Goldberg); claimed using the National Guard to stop crime was ‘a pretext to stop the next election!’ (Behar); and compared the election of Trump to … Hitler. (Behar: ‘The Germans voted also. Just saying.’)

The show has become such an embarrassment that the TV show ‘Landman’ mocked it for being a, ‘bunch of pissed off millionaires bitching about how much they hate millionaires, Trump, and men, and you, and me, and everybody else they got a bee up their ass about.’ ‘The View’ has gone from mindless propaganda to a punchline.

3. The first of the pod people

If you’re lucky, you’ve never heard of podcaster Jennifer Welch. Just imagine a ghoul-like figure from your deepest nightmares, then give her blonde hair and a microphone.

She’s one of the two co-hosts for the ‘I’ve Had It’ podcast, and it’s well-named. She and her co-host first appeared in the Bravo series ‘Sweet Home Oklahoma,’ which no one ever heard of. But now, the press loves her because she says hateful things about conservatives. 

CNN’s profile of Welch quotes her calling Trump a, ‘fat, fascist f— who’s ruining everything for everybody.’ The New York Times notes, ‘‘Patriots, gaytriots, theytriots, Blacktriots and browntriots,’ is how Ms. Welch greets the listeners of their primary podcast.’ She left out morontriots who must make up the bulk of her audience.

Welch made news calling Kirk’s widow Erika a ‘grifter’ and TPUSA said that comment was, ‘beneath contempt.’ 

I’m sure Welch will say worse in 2026 because the media reward her bile with support. CNN said she and her co-host are, ‘two women who love their country and aren’t afraid to name and shame people.’ 

See what I mean?

4. More pod-ish people 

Podcaster antisemite Nick Fuentes and Twitch antisemite Hasan Piker showed the world that the worst users of social media have one thing in common — hatred. Both of them have dominated the social world and been everywhere in the media as civilized society reacts in horror. 

Fuentes calls himself an admirer of communist Soviet dictator Joseph Stalin and says Nazi dictator Adolph Hitler was ‘really f—ing cool.’ Pretty much on brand.

Piker, when he’s not being accused of giving his dog electric shocks, spends his time saying offensive things, like, ‘America deserved 9/11.’ He later walked it back because of the backlash, but he still has millions of followers on multiple platforms. 

Fox News did an analysis of what he says, and it’s so vile, I don’t want to repeat it. He’s all across major media. The Times called him, ‘A Progressive Mind in a Body Made for the ‘Manosphere.’’ 

The press is desperate to recreate their own Joe Rogan and this is the best they’ve got.

5. Spacey

Singer Katy Perry had not one, but two spacey experiences in 2025. First, she sort-of went into space on a Jeff Bezos rocket. The owner of Amazon and the Washington Post sent his then-fiancée Lauren Sanchez, and five other famous women, into near-space. 

Perry is in the cool kids’ club, so she got to go. The singer actually vowed to ‘put the ‘a–’ in astronaut’ and made a fool of herself when she landed, kneeling and kissing the ground because of an 11-minute rocket trip. She was quoted declaring, ‘I feel super connected to love.’ 

That must have been true. She is now dating her own space cadet, former lefty Canadian Prime Minister Justin Trudeau.

6. Friday the 13th

Cynthia Erivo is 2025’s it gal. She’s everywhere and impossible not to see. As NBC put it, she’s ‘Proudly Bald and Has No Eyebrows.’ Throw in nails like Freddy Krueger and the bisexual star is everything the media want in a celebrity — weird and alternative. 

She’s the star of the two ‘Wicked’ movies and even played Jesus in the Hollywood Bowl (naturally) version of the musical ‘Jesus Christ Superstar.’ 

Erivo revels in her unusual look, even shaving her own eyebrows, ‘Whenever I’m talking to my makeup artist, I tell her that I just want to look like a pretty thumb.’ 

Yeah, I can’t top that.

7. It ain’t over till it’s over

The 2024 Democratic election debate wasn’t enough for Vice President Kamala Harris. Harris recently declared, ‘I am not done. I have lived my entire career a life of service, and it’s in my bones.’ Harris released her book, ‘107 Days’ and managed to annoy Democrats and Republicans about equally with her alleged recollection of events. 

At least former President Richard Nixon was nice enough to tell us, ‘You won’t have Nixon to kick around anymore.’ 

Harris will make us endure more garbled responses before she goes gently into that good night of her career.

This post appeared first on FOX NEWS

Lawmakers fought over Obamacare subsidies tooth and nail for the latter part of the year, and ultimately, neither side won.

Senate Democrats thrust the government into the longest shutdown in history in an effort to refocus the narrative in Congress on healthcare, and Republicans agreed to talk about it in the open. And both Republicans and Democrats got a shot to advance their own, partisan plans. Both failed.

Now, the subsidies are set to expire on Wednesday, sending price hikes across the desks of tens of millions of Americans that relied on the credits. 

When lawmakers return on the first week of January, healthcare will be front of mind for many in the Senate. But any push to either revive, or completely replace, the subsidies may, for a time, take a backseat to the government funding fight brewing ahead of the Jan. 30 deadline.

When asked if he was disappointed that lawmakers were unable to, at least in the short term, solve the subsidies issue, Sen. Josh Hawley, R-Mo., was more concerned about people that would experience higher costs. 

‘I think who it’s most disappointing for are the people whose premiums are going to go up by two, three times,’ Hawley said. ‘So, it’s not good.’

Price hikes on premium costs will be variable for the roughly 20 million Americans that rely on them, depending on age, income and other factors. Broadly, a person’s out-of-pocket cost is expected to double with the credit’s lapse, according to the Kaiser Family Foundation.

The nonpartisan healthcare think tank painted a broader picture of the disparate impact on premium cost increases in a report released late last month that, based on myriad factors, including where a person lives, their age range and where they sit above the poverty line, some could see price hikes as high as 361%.

While Senate Republicans’ and Democrats’ separate plans failed to advance — despite four Republicans crossing the aisle to support Senate Minority Leader Chuck Schumer’s, D-N.Y., plan — lawmakers are working together for a solution.

There are two plans with traction in the House. The GOP’s plan advanced on the floor earlier this month but doesn’t address the issue of the expiring tax credits. Then there is a bipartisan plan that calls for a three-year extension of the subsidies, similar to Senate Democrats’ plan, that is teed up for a vote.

The latter option, and its bipartisan momentum, has some Democrats hopeful that a three-year extension could get a shot in the upper chamber.

‘I’ll also say that the glimmer of hope is if we’re searching for a bipartisan deal that can pass the Congress, we don’t need to search any further than the three-year extension of the subsidies that’s going to pass the House of Representatives,’ Sen. Brian Schatz, D-Hawaii, told Fox News Digital. ‘We don’t need a negotiation any further. That bill can pass, if it can provide relief to the taxpayers, and it can pass, then that’s our vehicle.’

Senate Majority Leader John Thune, R-S.D., however, has maintained a deeply-rooted position against just a simple extension of the credits.

He argued that a straight-up extension for three years would be ‘a waste of $83 billion,’ and lacks any of the reforms that Republicans desire, like reinstalling an income cap, adding anti-fraud measures, and reaffirming language that would prevent taxpayer dollars from funding abortions.

‘I mean, I think if nothing else, depending on if the House sends something over here, there would be a new vehicle available,’ Thune said. ‘And if there is some bipartisan agreement on a plan, then you know, it’s possible that we could — obviously it’d have to be something that we think the House could pass, and the president would sign.’

‘But I’m not ruling anything out, I guess is what I’m saying,’ he continued. ‘But you know, a three-year extension of a failed program that’s rife with fraud, waste and abuse is not happening.’

Senate Democrats are open to negotiating on a bipartisan plan, something that is already ongoing after Sens. Susan Collins, R-Maine, and Bernie Moreno, R-Ohio, held a meeting with lawmakers before leaving Washington, D.C., earlier this month.

But Democrats are also making clear that they don’t want to budge on some of the Republicans’ demands.

‘Let’s put it this way, Republicans are asking to meet with me, and I’m telling them, I’ll listen, you know, I made it clear what I think is the only practical approach, and I’m certainly not going to go along with selling junk insurance,’ Sen. Ron Wyden, D-Ore., said.

This post appeared first on FOX NEWS

President Donald Trump spent much of 2025 attempting what had eluded his predecessors: personally engaging both Russian President Vladimir Putin and Ukrainian President Volodymyr Zelenskyy in an effort to bring an end to the war in Ukraine. From high-profile summits to direct phone calls, the administration pushed for a negotiated settlement even as the fighting ground on and the map changed little.

By year’s end, the outlines of a potential deal were clearer than they had been at any point since Russia’s full-scale invasion, with U.S. and Ukrainian officials coalescing around a revised 20-point framework addressing ceasefire terms, security guarantees and disputed territory. But 2025 also made clear why the war has proven so resistant to resolution: neither battlefield pressure, economic sanctions nor intensified diplomacy were enough to force Moscow or Kyiv into concessions they were unwilling to make.

The Trump administration’s push for a deal

The year began with a high-profile fallout last February between President Donald Trump, Vice President JD Vance and Ukrainian President Volodymyr Zelenskyy, when the Ukrainian leader stormed out of the White House after Trump told him he did not have ‘any cards’ to bring to negotiations with Russia.

Frustrated by the pace of talks after promising to end the war on ‘Day One’ of his presidency, Trump initially directed his ire toward Zelenskyy before later conceding that Moscow, not Kyiv, was standing in the way of progress.

‘I thought the Russia-Ukraine war was the easiest to stop but Putin has let me down,’ Trump said in September 2025.

That frustration had already surfaced publicly months earlier as Russian strikes continued despite diplomatic engagement. ‘He talks nice, and then he bombs everybody in the evening,’ Trump said in July.

Trump’s outreach to Russian President Vladimir Putin culminated in a high-profile summit in Alaska in August, though additional meetings were later called off amid a lack of progress toward a deal.

Still, Trump struck a more optimistic tone toward the end of the year. On Sunday, after meeting Zelenskyy at Mar-a-Lago, the president said the sides were ‘getting a lot closer, maybe very close’ to a peace agreement, while acknowledging that major obstacles remained — including the status of disputed territory such as the Donbas region, which he described as ‘very tough.’

Trump said the meeting followed what he described as a ‘very positive’ phone call with Putin that lasted more than two hours, underscoring the administration’s continued effort to press both sides toward a negotiated end to the war.

Where negotiations stand now

By the end of 2025, the diplomatic track had narrowed around a more defined — but still contested — framework. U.S. officials and Ukrainian negotiators have been working from a revised 20-point proposal that outlines a potential ceasefire, security guarantees for Ukraine, and mechanisms to address disputed territory and demilitarized zones.

Zelenskyy has publicly signaled openness to elements of the framework while insisting that any agreement must include robust, long-term security guarantees to deter future Russian aggression. Ukrainian officials have also made clear that questions surrounding occupied territory, including parts of the Donbas, cannot be resolved solely through ceasefire lines without broader guarantees.

Russia, however, has not agreed to the proposal. Moscow has continued to insist on recognition of its territorial claims and has resisted terms that would constrain its military posture or require meaningful concessions. Russian officials have at times linked their negotiating stance to developments on the battlefield, reinforcing the Kremlin’s view that leverage — not urgency — should dictate the pace of talks.

The result is a negotiation process that is more structured than earlier efforts, but still far from resolution: positions have hardened even as channels remain open, and talks continue alongside ongoing fighting rather than replacing it.

Russia’s territorial pressure — and Ukraine’s limited gains

Even as diplomacy intensified in 2025, the war on the ground remained defined by slow, grinding territorial pressure rather than decisive breakthroughs. Russian forces continued pushing for incremental gains in eastern and southern Ukraine, particularly along axes tied to Moscow’s long-stated objective of consolidating control over territory it claims as Russian.

Russian advances were measured and costly, often unfolding village by village through artillery-heavy assaults and sustained drone use rather than sweeping offensives. While Moscow failed to capture major new cities or trigger a collapse in Ukrainian defenses, it expanded control in parts of eastern and southern Ukraine, maintaining pressure across multiple fronts and keeping territorial questions central to both the fighting and any future negotiations.

Ukraine, for its part, did not mount a large-scale counteroffensive in 2025 comparable to earlier phases of the war. Ukrainian forces achieved localized tactical successes, at times reclaiming small areas or reversing specific Russian advances, but these gains were limited in scope and often temporary. None translated into a sustained territorial breakthrough capable of altering the broader balance of the front.

Instead, Kyiv focused on preventing further losses, reinforcing defensive lines and imposing costs on Russian forces through precision strikes and asymmetric tactics. With decisive territorial gains out of reach, Ukraine expanded attacks against Russian energy infrastructure, targeting refineries, fuel depots and other hubs critical to sustaining Moscow’s war effort — including sites deep inside Russian territory.

Russia, meanwhile, continued its own campaign against Ukraine’s energy grid, striking power and heating infrastructure as part of a broader effort to strain Ukraine’s economy, civilian resilience and air defenses. The result was a widening pattern of horizontal escalation, as both sides sought leverage beyond the front lines without achieving a decisive military outcome.

The result was a battlefield stalemate with movement at the margins: Russia advanced just enough to sustain its territorial claims and domestic narrative, while Ukraine proved capable of blunting assaults and imposing costs but not of reclaiming large swaths of occupied land. The fighting underscored a central reality of 2025 — territory still mattered deeply to both sides, but neither possessed the military leverage needed to force a decisive shift.

That dynamic would increasingly shape the limits of diplomacy. Without a major change on the battlefield, talks could test red lines and clarify positions, but not compel compromise.

Why talks stalled: leverage without decision

For all the diplomatic activity in 2025, negotiations repeatedly ran into the same obstacle: neither Russia nor Ukraine faced the kind of pressure that would force a decisive compromise.

On the battlefield, Russia continued to absorb losses while pressing for incremental territorial gains, reinforcing Moscow’s belief that time remained on its side. Ukrainian forces, though increasingly strained, succeeded in preventing a collapse and in imposing costs through deep strikes and attacks on Russia’s energy infrastructure — demonstrating an ability to shape the conflict even without major territorial advances.

Economic pressure also reshaped — but did not determine — Moscow’s calculus. Despite years of Western sanctions, Russia continued financing its war effort in 2025, ramping up defense production and adapting its economy to sustain prolonged conflict. While sanctions constrained growth and access to advanced technology, they raised the long-term costs of the war without producing the immediate pressure needed to force President Vladimir Putin toward concessions.

Those realities defined the limits of U.S. mediation. While the Trump administration pushed both sides to clarify red lines and explore possible frameworks for ending the war, Washington could illuminate choices without dictating outcomes, absent a decisive shift on the ground or a sudden change in Moscow’s calculations.

The result was a year of talks that clarified positions without closing gaps. As long as pressure produced pain without decision, negotiations could narrow options and define boundaries, even if they could not yet bring the conflict to an end.
 

This post appeared first on FOX NEWS

Lawmakers fought over Obamacare subsidies tooth and nail for the latter part of the year, and ultimately, neither side won.

Senate Democrats thrust the government into the longest shutdown in history in an effort to refocus the narrative in Congress on healthcare, and Republicans agreed to talk about it in the open. And both Republicans and Democrats got a shot to advance their own, partisan plans. Both failed.

Now, the subsidies are set to expire on Wednesday, sending price hikes across the desks of tens of millions of Americans that relied on the credits. 

When lawmakers return on the first week of January, healthcare will be front of mind for many in the Senate. But any push to either revive, or completely replace, the subsidies may, for a time, take a backseat to the government funding fight brewing ahead of the Jan. 30 deadline.

When asked if he was disappointed that lawmakers were unable to, at least in the short term, solve the subsidies issue, Sen. Josh Hawley, R-Mo., was more concerned about people that would experience higher costs. 

‘I think who it’s most disappointing for are the people whose premiums are going to go up by two, three times,’ Hawley said. ‘So, it’s not good.’

Price hikes on premium costs will be variable for the roughly 20 million Americans that rely on them, depending on age, income and other factors. Broadly, a person’s out-of-pocket cost is expected to double with the credit’s lapse, according to the Kaiser Family Foundation.

The nonpartisan healthcare think tank painted a broader picture of the disparate impact on premium cost increases in a report released late last month that, based on myriad factors, including where a person lives, their age range and where they sit above the poverty line, some could see price hikes as high as 361%.

While Senate Republicans’ and Democrats’ separate plans failed to advance — despite four Republicans crossing the aisle to support Senate Minority Leader Chuck Schumer’s, D-N.Y., plan — lawmakers are working together for a solution.

There are two plans with traction in the House. The GOP’s plan advanced on the floor earlier this month but doesn’t address the issue of the expiring tax credits. Then there is a bipartisan plan that calls for a three-year extension of the subsidies, similar to Senate Democrats’ plan, that is teed up for a vote.

The latter option, and its bipartisan momentum, has some Democrats hopeful that a three-year extension could get a shot in the upper chamber.

‘I’ll also say that the glimmer of hope is if we’re searching for a bipartisan deal that can pass the Congress, we don’t need to search any further than the three-year extension of the subsidies that’s going to pass the House of Representatives,’ Sen. Brian Schatz, D-Hawaii, told Fox News Digital. ‘We don’t need a negotiation any further. That bill can pass, if it can provide relief to the taxpayers, and it can pass, then that’s our vehicle.’

Senate Majority Leader John Thune, R-S.D., however, has maintained a deeply-rooted position against just a simple extension of the credits.

He argued that a straight-up extension for three years would be ‘a waste of $83 billion,’ and lacks any of the reforms that Republicans desire, like reinstalling an income cap, adding anti-fraud measures, and reaffirming language that would prevent taxpayer dollars from funding abortions.

‘I mean, I think if nothing else, depending on if the House sends something over here, there would be a new vehicle available,’ Thune said. ‘And if there is some bipartisan agreement on a plan, then you know, it’s possible that we could — obviously it’d have to be something that we think the House could pass, and the president would sign.’

‘But I’m not ruling anything out, I guess is what I’m saying,’ he continued. ‘But you know, a three-year extension of a failed program that’s rife with fraud, waste and abuse is not happening.’

Senate Democrats are open to negotiating on a bipartisan plan, something that is already ongoing after Sens. Susan Collins, R-Maine, and Bernie Moreno, R-Ohio, held a meeting with lawmakers before leaving Washington, D.C., earlier this month.

But Democrats are also making clear that they don’t want to budge on some of the Republicans’ demands.

‘Let’s put it this way, Republicans are asking to meet with me, and I’m telling them, I’ll listen, you know, I made it clear what I think is the only practical approach, and I’m certainly not going to go along with selling junk insurance,’ Sen. Ron Wyden, D-Ore., said.

This post appeared first on FOX NEWS

Escalating claims by Russia that Ukraine tried to hit a residence used by President Vladimir Putin with drones have been dismissed by a top military drone expert, who called the alleged attack ‘hard to fathom’ and tactically implausible.

Cameron Chell’s comments came as Moscow doubled down on accusations Kyiv has flatly denied, with the drone industry leader arguing the alleged strike announced Monday runs counter to Ukraine’s drone tactics.

Chell, the CEO and co-founder of Draganfly, a drone manufacturer that supplies to the U.S. Department of Defense and allied militaries, including Ukraine, said Russia’s claims lack credibility.

‘What really makes things usually very signature about Ukraine is that they are always incredibly clever about how they use drones,’ Chell told Fox News Digital.

‘They are clever from a cost perspective — let’s call it an efficiency perspective — but also very clever in their tactics,’ he added.

‘I find it hard to fathom that this drone attack even happened on Putin’s residence or that it was something that Ukraine orchestrated for a number of reasons,’ Chell said.

‘Based on the description of the alleged attack over the top of Putin’s residence, the drones would not have been launched from a very long distance away,’ he said.

‘This would have avoided up to 1000 km of air defense systems and then likely attacking one of the most heavily fortified air defense networks surrounding Putin’s Valdai residence.

‘The cost benefit analysis, not to mention the political analysis, also does not make sense,’ he added.

Chell’s comments came as Russia doubled down Tuesday on accusations that Ukraine attempted to strike a presidential palace in the Novgorod region using drones, allegedly to disrupt peace efforts.

Kyiv dismissed the allegation, with the timing also raising questions given the upbeat tone of a recent meeting between President Donald Trump and Ukrainian President Volodymyr Zelenskyy in Florida.

Russian Foreign Minister Sergey Lavrov claimed late Monday that 91 drones were intercepted en route to Putin’s residence on the shores of Lake Valdai.

His statement appeared to contradict earlier Defense Ministry tallies, which said 89 drones were shot down over eight regions, including 18 over Novgorod, later adding another 23.

Only after Lavrov spoke did the ministry allege that 49 drones intercepted over Bryansk, nearly 300 miles away, were also targeting Valdai.

Asked about wreckage, Kremlin spokesman Dmitry Peskov said it was ‘a matter for our military,’ while calling Zelenskyy’s denial and Western skepticism ‘completely insane.’

Peskov said Russia’s diplomatic stance would be toughened, and Duma Speaker Vyacheslav Volodin vowed there could be ‘no forgiveness’ for Zelenskyy.

Chell said the story simply does not add up. ‘To attack Putin’s residence in the manner described would require much more sophisticated tactics than simply sending long-range, relatively slow-moving drones,’ he said.

Chell also noted that this was a night operation and therefore, it generally rules out accurate visual mapping navigation. 

‘Since the description of the attack also does not lend itself to the use of fiber optic communication, which requires a relatively close range launch point, these drones would likely have had to rely on GPS navigation,’ he explained.

‘This would easily have been thwarted in this area and the Ukrainians would have known this,’ Chell said.

Politically, Chell argued, Ukraine has nothing to gain. ‘They’re bold, but right in the middle of peace talks — when they need Trump on side — it makes no sense,’ he said. ‘Ukraine is just politically too smart to have done that.’

Zelenskyy on Monday also called the claim a complete fabrication, accusing Moscow of laying the groundwork for further attacks. 

Lavrov warned of retaliation but said Russia would continue talks with Washington.

Trump also said he learned of the alleged attack directly from Putin and was ‘very angry about it.’ Asked whether there was evidence, Trump replied, ‘We’ll find out.’

Fox News Digital has reached out to the Kremlin for comment.

This post appeared first on FOX NEWS

Investor Insight

Silver Dollar Resources is repositioning its flagship La Joya silver-gold-copper project to unlock high-grade underground potential in Mexico’s prolific Durango-Zacatecas silver belt. Strengthened by the all-share sale of its Ranger-Page project to Bunker Hill Mining, the company offers investors leveraged exposure to near-term silver (zinc-lead) production in Idaho’s Silver Valley, while remaining fully funded to advance exploration across its core portfolio through 2026.

Overview

Silver Dollar Resources (CSE:SLV,OTCQX:SLVDF,FSE:4YW) is a precious metals exploration company focused on advancing high-grade silver and gold opportunities in Mexico. The company’s primary asset is the La Joya silver-gold-copper project, located in the southern portion of the Durango-Zacatecas silver belt, one of the world’s most productive silver regions.

La Joya has been the subject of extensive historical exploration, including more than 51,600 meters of drilling across 182 drill holes. This work outlined multiple mineralized zones, including the Main Mineralized Trend, Santo Niño and Coloradito. Silver Dollar is re-evaluating the project with an underground-focused exploration model, supported by structural analysis, underground sampling and reassessment of historic drill core to identify higher-grade targets at depth.

The company also owns the Nora silver-gold project in Durango, Mexico, which hosts the historic Candy mine and epithermal vein system that has returned high-grade surface sampling results. In addition, Silver Dollar holds an equity position in Bunker Hill Mining following the sale of the Ranger-Page project, providing equity exposure to the planned production restart in Idaho’s Silver Valley in the first 2026.

Silver Dollar is supported by an experienced management and technical team with expertise in underground exploration, epithermal systems and project evaluation. With a strong treasury, active exploration programs and multiple upcoming catalysts, the company is positioned to deliver exploration progress through 2026.

Company Highlights

  • 100 percent owned La Joya project, an advanced-stage silver-gold-copper system in Mexico’s Durango-Zacatecas silver belt
  • La Joya was originally proposed as an open pit in 2013 based on US$24 silver, US$1,200 gold and US$3 copper
  • Strategic shift toward evaluating La Joya’s high-grade underground potential supported by new 3D geological modeling, underground sampling, and drill target development
  • Completed sale of the Ranger-Page project to Bunker Hill Mining, providing equity exposure to a near-term US silver producer
  • Fully funded to carry out planned exploration programs through 2026
  • Largest shareholder is mining investor Eric Sprott, with approximately 17.5 percent ownership
  • Multiple exploration catalysts planned, including drilling at La Joya in early 2026

Key Projects

La Joya Silver-Gold-Copper Project

The La Joya project is Silver Dollar’s 100 percent owned flagship asset. It is located within the Durango-Zacatecas silver belt, which hosts numerous past-producing and operating mines, including assets operated by First Majestic Silver, Grupo México, Industrias Peñoles and Pan American Silver.

Historical exploration at La Joya outlined multiple zones of mineralization, including the Main Mineralized Trend, Santo Niño and Coloradito, with mineralization occurring as skarn, replacement and vein-style systems. Previous work was largely oriented toward evaluating open-pit potential.

Silver Dollar is advancing a reinterpretation of La Joya as a potential high-grade underground system. Recent work includes:

  • Underground sampling from historic workings, returning values of up to 2,753 grams per metric ton (g/t) silver equivalent
  • Identification of the Central Dyke zone over approximately 770 meters, including a sample returning 3,513 g/t (~124 oz/ton) silver
  • Discovery of the Brazo zone, located approximately 1 kilometer west of the Main Mineralized Trend, with Phase II drilling returning up to 451 g/t silver over 5 meters
  • The Brazo Zone provides evidence of deeper, high-grade mineralization at La Joya
  • Development of new 3D geological models is in progress incorporating the large database of structural, geochemical and fault-kinematic analysis

Silver Dollar plans to advance a new phase of drilling at La Joya in the first quarter of 2026, with a focus on testing high-grade underground targets identified through recent modeling and sampling.

Nora Silver-Gold Project

The Nora project is located in Durango, Mexico, within the same regional silver trend as several major operations. The property hosts an epithermal vein system known as the Candy vein.

Geological mapping and surface sampling have returned high-grade gold, silver and base metal values, including samples grading up to 29.61 g/t gold and 2,215 g/t silver, along with locally elevated copper, lead and zinc values.

In 2025, Silver Dollar identified the North Canyon zone, located approximately 1.5 kilometers north of the historic Candy mine. Channel sampling returned 162 g/t silver equivalent over 12.48 meters within a broad oxidation zone. Ongoing mapping and trenching are being used to define drill targets for potential drill testing in the first quarter of 2026.

Ranger-Page Project (Sold)

Silver Dollar acquired the Ranger-Page silver-lead-zinc project in Idaho’s Silver Valley in August 2024 and agreed to sell the asset to neighbor Bunker Hill Mining in October 2025 for C$3.5 million, payable by the issuance of 23,333,334 Bunker Hill shares at a deemed price of C$0.15 per share. The sale closed in December and the value of those Bunker Hill shares at the time of closing was approximately $5.8 million.

The Ranger-Page project is geologically contiguous with the Bunker Hill mine system. The transaction provides Silver Dollar with equity exposure to Bunker Hill’s planned production restart in the first half of 2026. Teck Resources owns ~32 percent of Bunker Hill and has life-of-mine off-take agreement for 100 percent of the zinc and lead production. Silver Dollar expects Bunker Hill to receive increased analyst coverage and a higher valuation next year as production commences.

Red Lake Area Properties

Silver Dollar also holds two 100 percent owned gold grassroots exploration properties in Ontario’s Red Lake mining division: Pakwash Lake and Longlegged Lake. Early-stage work has included airborne magnetic surveys, geological mapping and surface sampling, identifying structural and geophysical targets associated with the Pakwash Lake Fault Zone.

While not a primary focus, the properties provide optionality in a well-established gold district with major Kinross Gold discovery drilling on the Dixie Halo property that adjoins both properties to the north.

Management Team

Gregory Lytle — President, CEO and Director

Gregory Lytle has more than 20 years of experience advising mineral exploration companies on corporate strategy, capital markets and communications. Prior to becoming CEO in 2025, Lytle served as a consultant to Silver Dollar and has facilitated more than $100 million in financings for mining-sector clients.

J.J. (Jeff) Smulders — CFO, Corporate Secretary and Director

Jeff Smulders has more than 45 years of experience in accounting, taxation and financial management. He has provided financial consulting services to public and private companies for more than 25 years.

Bruce MacLachlan — Independent Director

Bruce MacLachlan is an exploration professional with more than four decades of experience across grassroots and advanced-stage projects. He has worked with companies including Noranda, Hemlo Gold, Battle Mountain and Noront.

Guillermo Lozano-Chávez — Independent Director

Guillermo Lozano-Chávez is a geologist with more than 40 years of experience in exploration and mine management across the Americas. He previously served as vice president of exploration at First Majestic Silver.

Dale Moore — Exploration Manager and Qualified Person

Dale Moore is an underground-focused geologist with more than a decade of experience in Idaho’s Coeur d’Alene Mining District. His work includes major deposits such as Lucky Friday and the Galena Complex, and he leads technical work at La Joya.

Mark Malfair — Country Manager, Mexico

Mark Malfair is a bilingual geologist with more than 25 years of experience in exploration and project management in Mexico, including previous work at Chesapeake Gold’s Metates project.

This post appeared first on investingnews.com

LaFleur Minerals Inc. (CSE: LFLR,OTC:LFLRF) (FSE: 3WK0) (‘LaFleur Minerals’ or the ‘Company’ or ‘Issuer’) is pleased to announce that, further to its news releases dated December 15, 2025, and December 16, 2025, the Company has completed its previously announced non-brokered private placement of units of the Company (the ‘LIFE Units’) at a price of $0.50 per Unit under the Listed Issuer Financing Exemption (as defined herein) for an upsized amount and gross proceeds of $4,695,000 (the ‘LIFE Offering’). The Company also announces that it has closed its previously announced Flow-Through Offering (the ‘FT Units’) at a price of $0.60 per flow-through unit for an oversubscribed amount and gross proceeds of $2,205,421.

With both these financings closed, upsized due to demand and oversubscribed, LaFleur is now funded for the restart of its Beacon Gold Mill, intending to source mineralized material from its nearby Swanson Gold Project, and starting with an estimated 10,000-20,000 metric tons (mt) of mineralized stockpiles remaining on the site of its wholly-owned Beacon Gold Mill.

FMI Securities Inc. acted as a special advisor and selling group member on the closed LIFE and FT Offerings, along with participation from other key investment banks and advisory firms such as Red Cloud Securities Inc., Ventum Financial Corp., Canaccord Genuity Group Inc., Research Capital Corp., Raymond James Ltd. and Stonegate Securities Ltd.

Beacon Gold Mill: A Strategic, High-Value Infrastructure Asset

The Company is uniquely positioned as one of the few junior gold companies in Canada that owns a fully permitted, existing gold mill, providing a clear pathway to cash flow without the long timelines, dilution, and capital intensity typically associated with mill construction. The completion of these financings materially de-risks LaFleur’s business model, enabling the Company to advance directly into gold production at its Beacon Gold Mill while simultaneously unlocking value from its nearby Swanson Gold Project. This vertically integrated strategy allows LaFleur to control the full value chain, from mineralized material to doré, creating the potential for early revenue generation, margin capture, and shareholder value accretion.

LaFleur’s wholly-owned Beacon Gold Mill represents a rare and highly strategic asset within the Abitibi Gold Belt. The 750 tpd mill is fully constructed, in good condition, permitted, historically proven, and ready for restart of operations, significantly reducing execution risk and capital requirements compared to greenfield development scenarios. With funding now secured, the Company intends to restart mill operations and advance toward gold production, with impending Preliminary Economic Assessment (‘PEA’) results expected mid-January, positioning LaFleur as the newest producer in one of the world’s most prolific gold districts. Led by Environmental Resources Management (ERM), a global mining, sustainability, and environmental consulting firm with extensive technical mining expertise, the PEA is conducted for the purpose of evaluating the restart of gold production at LaFleur’s wholly-owned and recently refurbished Beacon Gold Mill using mineralized material from its nearby Swanson Gold Deposit, both located in the recognized mining camp of Val-d’Or, Québec. Ownership of the Beacon Gold Mill provides LaFleur with operational flexibility and optionality, including the ability to process mineralized material from its own project and potentially third-party feed from regional deposits, creating additional revenue opportunities beyond its core assets.

Swanson Gold Project: High-Grade Feed Potential Close to the Mill

The Swanson Gold Project, located in close proximity to the Beacon Gold Mill, is a cornerstone of LaFleur’s production strategy. The project hosts various showings of high-grade gold mineralization within the Abitibi Greenstone Belt, positioned in an area renowned for producing over 200 million ounces of gold historically. The Company plans to advance Swanson as a primary source of mill feed, leveraging short haul distances to reduce operating costs and enhance project economics. With funding in place, LaFleur can aggressively advance exploration and development activities at Swanson, targeting the definition of near-surface, high-grade zones that could be rapidly transitioned into production. This approach supports a low-capex, staged production model designed to generate cash flow while continuing to grow the resource base.

Beacon-Swanson Synergy: A Clear Path to Value Creation

The combination of a wholly-owned, restart-ready gold mill and a nearby, district-scale gold project with high-grade potential, positions LaFleur Minerals as a differentiated junior gold company with a clear and executable growth strategy. Being funded enables the Company to move decisively toward production, reduce financing risk, and focus on operational execution. Management believes this milestone places LaFleur in a strong position to deliver near-term production, establish cash flow, and build a scalable gold platform in Québec, creating long-term value for shareholders as the Company advances toward becoming a sustainable gold producer.

Financing Details

Each Unit of the LIFE Offering consists of one common share in the capital of the Company (a ‘LIFE Share‘) and one transferrable common share purchase warrant (a ‘LIFE Warrant‘). Each Warrant entitled the holder to purchase one additional common share at a price of $0.75 for a period of 36 months from the date of issuance. Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 – Prospectus Exemptions (‘NI 45-106‘), the LIFE Offering was made to purchasers’ resident in all provinces of Canada, except Quebec, pursuant to the listed issuer financing exemption under Part 5A of NI 45-106 (the ‘Listed Issuer Financing Exemption‘). The securities offered under the Listed Issuer Financing Exemption are not subject to a hold period in accordance with applicable Canadian securities laws.

Each Unit of the Flow-Through Offering consists of one common share in the capital of the Company, to be issued as a ‘flow-through share’ within the meaning of the Income Tax Act (Canada) and the Taxation Act (Québec) (each, a ‘FT Share‘), and one transferrable common share purchase warrant (a ‘FT Warrant‘). Each Warrant entitled the holder to purchase one additional common share at a price of $0.75 for a period of 24 months from the date of issuance. The Warrants are subject to an accelerated expiry upon thirty (30) business days’ notice from the Company in the event the closing price of the Company’s common shares on the Canadian Securities Exchange (the ‘CSE‘) is equal to or above a price of $0.90 for fourteen (14) consecutive trading days any time after closing of the Offering.

In connection with the LIFE and FT Offerings, the Company paid an aggregate cash finder fee of $480,229.43 and issued an aggregate of 909,466 non-transferable finders’ warrants (each, a ‘Finder’s Warrant‘). Each Finder’s Warrant entitles the holder to acquire one common share in the capital of the Company at a price of $0.75 each for a period of 24 months from the date of issuance, all in accordance with the policies of the CSE.

The gross proceeds from the LIFE Offering will be used for the advancement of exploration initiatives at the Company’s Swanson Gold Project and for operational purposes for the restart of gold production operations at the Company’s wholly-owned Beacon Gold Mill, in addition to working capital and general corporate expenses.

This news release is not an offer to sell or the solicitation of an offer to buy the securities in the United States or in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of such jurisdiction. The securities referred to in this news release have not been, nor will they be, registered under the United States Securities Act of 1933, as amended (the ‘U.S. Securities Act’), and such securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons absent an exemption from registration under the U.S. Securities Act and applicable U.S. state securities laws. ‘United States’ and ‘U.S. person’ are as defined in Regulation S under the U.S Securities Act.

About LaFleur Minerals Inc.

LaFleur Minerals Inc. (CSE: LFLR,OTC:LFLRF) (FSE: 3WK0) is focused on the development of district-scale gold projects in the Abitibi Gold Belt near Val-d’Or, Québec. Our mission is to advance mining projects with a laser focus on our resource-stage Swanson Gold Deposit and the Beacon Gold Mill, which have significant potential to deliver long-term value. The Swanson Gold Project is approximately 18,304 hectares (183 km2) in size and includes several prospects rich in gold and critical metals previously held by Monarch Mining, Abcourt Mines, and Globex Mining. LaFleur has recently consolidated a large land package along a major structural break that hosts the Swanson, Bartec, and Jolin gold deposits and several other showings which make up the Swanson Gold Project. The Swanson Gold Project is easily accessible by road allowing direct access to several nearby gold mills, further enhancing its development potential. Lafleur Mineral’s fully refurbished and permitted Beacon Gold Mill is capable of processing over 750 tonnes per day and is being considered for processing mineralized material at Swanson and for custom milling operations for other nearby gold projects.

ON BEHALF OF LaFleur Minerals INC.

Paul Ténière, M.Sc., P.Geo.
Chief Executive Officer
E: info@lafleurminerals.com
LaFleur Minerals Inc.
1500-1055 West Georgia Street
Vancouver, BC V6E 4N7

Neither the Canadian Securities Exchange nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this news release.

Cautionary Statement Regarding ‘Forward-Looking’ Information

This news release includes certain statements that may be deemed ‘forward-looking statements’. All statements in this new release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words ‘expects’, ‘plans’, ‘anticipates’, ‘believes’, ‘intends’, ‘estimates’, ‘projects’, ‘potential’ and similar expressions, or that events or conditions ‘will’, ‘would’, ‘may’, ‘could’ or ‘should’ occur. Forward-looking statements in this news release include, without limitation, statements related to the anticipated use of proceeds from the LIFE Offering. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Factors that could cause the actual results to differ materially from those in forward-looking statements include market prices, continued availability of capital and financing, and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements. Forward-looking statements are based on the beliefs, estimates and opinions of the Company’s management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management’s beliefs, estimates or opinions, or other factors, should change.

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATES

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/279262

News Provided by Newsfile via QuoteMedia

This post appeared first on investingnews.com

The NASDAQ Biotechnology Index (INDEXNASDAQ:NBI) is trading at three year highs despite market volatility, responding to breakthrough innovations and increased deals involving NASDAQ biotech stocks.

After dropping to a low of 3,637.05 in October 2023, the index climbed to a nearly three year peak of 4,954.813 on September 19, 2024. While the index pulled back to 4,530.69 in August 2025, it staged a robust recovery in the second half of the year, closing at 5,766.59 on December 29, 2025, a gain of approximately 34 percent for the year.

The top NASDAQ biotech stocks have seen sizeable share price increases over the past year. For those interested in investing in biotech companies, the best-performing small-cap biotech stocks are outlined below.

Data was gathered on December 29, 2025, using TradingView’s stock screener. Small-cap biotech stocks with market caps between US$50 million and US$500 million at that time were considered for this list.

1. SELLAS Life Sciences Group (NASDAQ:SLS)

Year-to-date gain: 210.19 percent
Market cap: US$477.18 million
Share price: US$3.35

SELLAS Life Sciences Group is a late-stage biopharmaceutical company focused on novel cancer immunotherapies. The company’s approach involves ‘teaching’ the immune system to recognize and kill cancer cells by targeting specific proteins that are overexpressed in tumors.

Its flagship asset is galinpepimut-S (GPS), a vaccine-like immunotherapy for patients with acute myeloid leukemia (AML) who are in remission but at high risk of relapse. Its secondary asset, SLS009, is a highly selective CDK9 inhibitor currently showing promise in Phase 2 trials for various blood cancers.

The company’s stock price surged on December 29 after SELLAS shared an update on the Phase 3 REGAL trial evaluating GPS as a maintenance therapy in patients with AML. The trial is designed as a blind survival study, with the end point triggered on the 80th patient death.

In the update, the company reported that 72 deaths had occurred as of December 26. Because it is taking longer than expected for the trial to complete, which was previously anticipated to happen before the end of 2025, investors are speculating that the patients in the trial are living significantly longer than the historical average.

2. IO Biotech (NASDAQ:IOBT)

Year-to-date gain: 129.47 percent
Market cap: US$144.28 million
Share price: US$2.16

IO Biotech is developing immune-modulating therapeutic cancer vaccines based on its T-win technology platform, designed to activate T cells to target both tumor cells and the immune-suppressive cells.

The clinical-stage biopharmaceutical company’s lead cancer vaccine candidate is IO102-IO103, which has the brand name Cylembio. IO102-IO103 has breakthrough therapy designation from the US Food and Drug Administration (FDA) when used in combination with Merck’s (NYSE:MRK) anti-PD-1 therapy Keytruda for the treatment of advanced melanoma based on positive Phase 1/2 first line metastatic melanoma data.

The candidate reached a major milestone in August 2025 with the readout of its pivotal Phase 3 trial of IO102-IO103 with Keytruda for treating advanced melanoma. While the vaccine combined with Keytruda showed a significant survival benefit — reaching 19.4 months of progression-free survival compared to 11 months for Keytruda alone — it narrowly missed the strict statistical significance threshold.

Following a December meeting with the FDA to discuss a path forward for Cylembio, IO Biotech ended the year focused on a new registrational trial to address the Phase 3 miss and securing further funding to extend its operations into 2026.

Throughout 2025, the company continued to expand its pipeline. In November, it presented new pre-clinical data for IO112 targeting arginase 1 and for IO170 targeting transforming growth factor.

3. Tiziana Life Sciences (NASDAQ:TLSA)

Year-to-date gain: 124.64 percent
Market cap: US$184.22 million
Share price: US$1.55

Tiziana Life Sciences is a clinical-stage biopharma which is developing therapies for autoimmune and inflammatory diseases, degenerative diseases and cancer-related to the liver. Its pipeline of candidates is built on its patented drug delivery technology that provides a possible alternative to intravenous delivery.

Tiziana’s lead candidate is intranasal foralumab, a fully human anti-CD3 monoclonal antibody, which it is currently studying for treatment of a range of conditions.

In March, the company filed an investigational new drug application with the FDA for a Phase 2 clinical trial in amyotrophic lateral sclerosis (ALS), which is supported by the ALS Association. The Phase 2 trial is slated to begin in January 2026. Tiziana also began dosing patients in a Phase 2a trial for multiple system atrophy in August.

In April, John Hopkins University and the University of Massachusetts commenced dosing of the biotech company’s intranasal foralumab in Phase 2 trials for patients with non-active secondary progressive multiple sclerosis (MS). On May 7, the company shared positive results from the use of its lead candidate in improving the quality of life for patients with that form of MS.

Tiziana is also studying the use of intranasal foralumab for treating moderate Alzheimer’s disease. On May 9, it announced that PET scans of a patient with moderate Alzheimer’s showed a significant reduction in microglia activation associated with neuroinflammation after three months of treatment.

On July 21, the company announced an ‘unexpected discovery’ following immunologic analysis of the patient with Alzheimer’s disease: ‘The analysis revealed an increase in phagocytosis markers in classical monocytes, suggesting that nasal foralumab may enhance their ability to clear amyloid plaques. This unexpected effect may open new avenues for treating Alzheimer’s Disease by targeting both inflammation and amyloid accumulation.’

The company dosed the first patient in its randomized Phase 2 Alzheimer’s trial in December.

To end the year, Tiazana submitted a comprehensive safety report to the FDA documenting over 37 patient-years of treatment with no serious drug-related adverse events across its studies.

4. Spero Therapeutics (NASDAQ:SPRO)

Year-to-date gain: 119.05 percent
Market cap: US$129.58 million
Share price: US$2.30

Spero Therapeutics is developing novel treatments for rare diseases and multi-drug resistant bacterial infections with high unmet need.

The company’s lead drug candidate is tebipenem pivoxil hydrobromide (HBr), a late-stage development asset developed in collaboration with pharma giant GSK (NYSE:GSK). GSK has an exclusive license agreement to commercialize the drug candidate in most markets.

Tebipenem HBr is an oral carbapenem developed to treat complicated urinary tract infections (cUTIs), including pyelonephritis. The FDA granted tebipenem HBr qualified infectious disease product and fast-track designations.

Spero’s stock surged 245 percent on May 28 to reach US$2.35 after the company reported that its Phase 3 trial evaluating tebipenem HBr for treating cUTIs met its primary endpoint and stopped early for efficacy.

On December 19, GSK officially filed the new drug application resubmission to the FDA for tebipenem HBr for treating cUTIs supported by the Phase 3 results. This filing triggered a US$25 million milestone payment to Spero that is expected in Q1 2026.

5. OKYO Pharma (NASDAQ:OKYO)

Year-to-date gain: 60.50 percent
Market cap: US$74.85 million
Share price: US$1.91

OKYO Pharma is a clinical-stage biopharma company developing therapies for the treatment of neuropathic corneal pain and dry eye disease. Its lead candidate is urcosimod, a non-steroidal anti-inflammatory and non-opioid analgesic.

OKYO is currently evaluating urcosimod for the treatment of neuropathic corneal pain. The treatment received fast track designation from the FDA in May after the company ended its Phase 2 clinical trial early to analyze data.

On July 17, the company posted strong top-line data from the Phase 2 trial and stated it is planning a meeting with the FDA to discuss next steps for its lead drug candidate. The following day, OKYO received US$1.9 million in non-dilutive funding to support its clinical development of urcosimod.

In September, OKYO announced a 120 patient, multi-center multiple ascending dose clinical trial designed to identify the optimal dose for Phase 3 registration.

A scientific breakthrough followed on December 11, when new imaging data revealed that urcosimod may actually help restore corneal nerve structure, showing median increases in nerve fiber count and length, while those in the placebo group saw median decreases for both.

Securities Disclosure: I, Meagan Seatter, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Sankamap Metals Inc. (CSE: SCU) (‘Sankamap’ or the ‘Company’) the Company and its auditor continue to work diligently toward the completion and filing of the Company’s annual audited financial statements and management’s discussion and analysis for the fiscal year ended June 30, 2025 (the ‘Required Filings’). The Company has applied to the Alberta Securities Commission for an extension of the Management Cease Trade Order (‘MCTO’), however, there can be no assurance that a further extension will be granted. The additional delay in completing the Required Filings is primarily due to the auditor awaiting the receipt of certain required information from government authorities in Solomon Islands, as well as timing constraints associated with the holiday period. The Company estimates that approximately 90% of the audit work has been completed.

The Required Filings were due to be filed by October 28, 2025. In connection with the anticipated delays in making the Required Filings, the Company made an application for a Management Cease Trade Order (‘MCTO‘) under National Policy 12-203 Management Cease Trade Orders (‘NP 12-203‘) to the Alberta Securities Commission, as principal regulator for the Company, and the MCTO was issued on October 29, 2025. The MCTO restricts all trading by the Company’s CEO and CFO in securities of the Company, whether direct or indirect. The MCTO does not affect the ability of persons who are not directors, officers or insiders of the Company to trade their securities. The MCTO will remain in effect until the Required Filings are filed or until it is revoked or varied.

The Company expects to proceed with the filing of its interim first-quarter financial statements shortly after the Required Filings have been completed and submitted.

The Company confirms that it intends to satisfy the provisions of the alternative information guidelines described in NP 12-203 by issuing bi-weekly default status reports in the form of a news release until it meets the Required Filings requirement. The Company has not taken any steps towards any insolvency proceeding and the Company has no material information relating to its affairs that has not been generally disclosed.

For further information with respect to the MCTO, please refer to the Company’s news releases dated October 21, 2025, November 4, 2025, November 18, 2025, December 3, 2025 and December 17, 2025, available for viewing on the Company’s SEDAR+ profile at www.sedarplus.ca.

About Sankamap Metals Inc.

Sankamap Metals Inc. (CSE: SCU) is a Canadian mineral exploration company dedicated to the discovery and development of high-grade copper and gold deposits through its flagship Oceania Project, located in the South Pacific. The Company’s fully permitted assets are strategically positioned in the Solomon Islands, along a prolific geological trend that hosts major copper-gold deposits; including Newcrest’s Lihir Mine, with a resource of 71.9 million ounces of gold¹ (310 Mt containing 23 Moz Au at 2.3 g/t P+P, 520 Mt containing 39 Moz Au at 2.3 g/t indicated, 81 Mt containing 5 Moz Au at 1.9 g/t measured, 61 Mt containing 4.9 Moz Au at 2.3 g/t Inferred).

Exploration is actively advancing at both the Kuma and Fauro properties, part of Sankamap’s Oceania Project in the Solomon Islands. Historical work has already highlighted the mineral potential of both sites, which lie along a highly prospective copper and gold-bearing trend, suggesting the possibility of further, yet-to-be-discovered deposits.

At Kuma, the property is believed to host an underexplored and largely untested porphyry copper-gold (Cu-Au) system. Historical rock chip sampling has returned consistently elevated gold values above 0.5 g/t Au, including a standout sample assaying 11.7% Cu and 13.5 g/t Au2; underscoring the area’s significant potential.

At Fauro, particularly at the Meriguna Target, historical trenching has returned highly encouraging results, including 8.0 meters at 27.95 g/t Au and 14.0 meters at 8.94 g/t Au3. Complementing these results are exceptional grab sample assays, including historical values of up to 173 g/t Au3, along with recent sampling by Sankamap at the Kiovakase Target, which returned numerous high-grade copper values, reaching up to 4.09% Cu. In addition, limited historical shallow drilling intersected 35.0 meters at 2.08 g/t Au3, further underscoring the property’s strong mineral potential and the merit for continued exploration. With a commitment to systematic exploration and a team of experienced professionals, Sankamap aims to unlock the untapped potential of underexplored regions and create substantial value for its shareholders. For more information, please refer to SEDAR+ (www.sedarplus.ca), under Sankamap’s profile.

1.Newcrest Technical Report, 2020 (Lihir: 310 Mt containing 23 Moz Au at 2.3 g/t P+P, 520 Mt containing 39 Moz Au at 2.3 g/t indicated, 81 Mt containing 5 Moz Au at 1.9 g/t measured, 61 Mt containing 4.9 Moz Au at 2.3 g/t Inferred)

2. Historical grab, soil and BLEG samples from SolGold Kuma Review June 2015, and SolGold plc Annual Report 2013/2012

3. September 2010-June 2012 press releases from Solomon Gold Ltd. and SolGold Fauro Island Summary Technical Info 2012

QP Disclosure

The technical content for the Oceania Project in this news release has been reviewed and approved by John Florek, M.Sc., P.Geol., a Qualified Person in accordance with CIM guidelines. Mr. John Florek is in good standing with the Professional Geoscientists of Ontario (Member ID:1228) and a director and officer of the Company.

ON BEHALF OF THE BOARD OF DIRECTORS

s/ ‘John Florek’
John Florek, M.Sc., P.Geol
Chief Executive Officer
Sankamap Metals Inc.

Contact:
John Florek, CEO
T: (807) 228-3531
E: johnf@sankamap.com

The Canadian Securities Exchange has not approved nor disapproved this press release.

Forward-Looking Statements

Certain statements made and information contained herein may constitute ‘forward-looking information’ and ‘forward-looking statements’ within the meaning of applicable Canadian and United States securities legislation. These statements and information are based on facts currently available to Sankamap and there is no assurance that the actual results will meet management’s expectations. Forward-looking statements and information may be identified by such terms as ‘anticipates,’ ‘believes,’ ‘targets,’ ‘estimates,’ ‘plans,’ ‘expects,’ ‘may,’ ‘will,’ ‘could’ or ‘would.’

This press release contains forward-looking statements, including, but not limited to, statements regarding management’s expectations about obtaining the MCTO and completing the Required Filings within the anticipated timeline. Forward-looking statements are subject to various risks, uncertainties, and other factors that could cause actual results or events to differ materially from those expressed or implied by such statements. Sankamap does not undertake any obligation to update forward-looking statements or information, except as required by applicable securities laws. For more information on the Company, investors should review the Company’s continuous disclosure filings that are available at www.sedarplus.ca.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/279270

News Provided by Newsfile via QuoteMedia

This post appeared first on investingnews.com

TORONTO, ON / ACCESS Newswire / December 31, 2025 / NextSource Materials Inc. (TSX:NEXT,OTC:NSRCF)(OTCQB:NSRCF) (‘NextSource’ or the ‘Company’) is pleased to announce the results of the Annual Meeting of Shareholders of the Company (the ‘Meeting’) held virtually at 8:00 AM (Toronto time) on December 30, 2025.

AGM Results

The final voting results of the Meeting are set out below:

  1. Election of Directors. The Company’s shareholders elected each of the nominees as directors to serve until the next annual meeting of shareholders, or until their respective successors are elected or appointed. The following table sets forth the voting results with respect to the election of directors:

Nominee

For

Against

Sir Mick Davis

99.6%

0.4%

Hanré Rossouw

99.5%

0.5%

Christopher Kruba

99.7%

0.3%

Ian Pearce

99.7%

0.3%

Craig Scherba

99.5%

0.5%

Brett Whalen

99.5%

0.5%

2. Appointment of Auditor. The Company’s shareholders approved the appointment of PricewaterhouseCoopers LLP, Chartered Professional Accountants, as the Company’s auditors for the fiscal year ending June 30, 2026 and that the Board of Directors is authorized to fix their remuneration. The following table sets forth the voting results with respect to the appointment of PricewaterhouseCoopers LLP:

For

Withheld

99.9%

0.1%

A total of 101,161,308 common shares equivalent to 54.7% of the common shares entitled to vote were represented in person or by proxy at the Meeting.

ABOUT NextSource Materials Inc.

NextSource Materials Inc. is a battery materials company based in Toronto, Canada that is intent on becoming a vertically integrated global supplier of battery materials through the mining and value-added processing of graphite and other minerals.

The Company’s Molo graphite project in Madagascar is one of the largest known and highest-quality graphite resources globally, and the only one with SuperFlake® graphite. The Molo mine has begun production through Phase 1 mine operations.

The Company is also developing a significant downstream graphite value-add business through the staged rollout of Battery Anode Facilities (BAF) capable of large-scale production of coated, spheronized and purified graphite for direct delivery to battery and automotive customers, in a fully transparent and traceable manner. The Company is now in the process of developing its first BAF in the UAE.

NextSource Materials is listed on the Toronto Stock Exchange under the symbol ‘NEXT’ and on the OTCQB under the symbol ‘NSRCF’.

For further information about NextSource Materials, please visit our website at www.nextsourcematerials.com or contact us at +1.416.364.4911 or email Brent Nykoliation, Executive Vice President at brent@nextsourcematerials.com.

CAUTIONARY NOTE

This press release contains statements that may constitute ‘forward-looking information’ or ‘forward-looking statements’ within the meaning of applicable Canadian and United States securities legislation. Readers are cautioned not to place undue reliance on forward-looking information or statements. Forward looking statements and information are frequently characterized by words such as ‘plan’, ‘expect’, ‘project’, ‘intend’, ‘believe’, ‘anticipate’, ‘estimate’, ‘potential’, ‘possible’ and other similar words, or statements that certain events or conditions ‘may’, ‘will’, ‘could’, or ‘should’ occur. Forward- looking statements include any statements regarding, among others, reaching nameplate production capacity and the rollout of Battery Anode Facilities including the capabilities and the timing and economics thereof. These statements are based on current expectations, estimates and assumptions that involve a number of risks, which could cause actual results to vary and, in some instances, to differ materially from those anticipated by the Company and described in the forward-looking statements contained in this press release. No assurance can be given that any of the events anticipated by the forward-looking statements will transpire or occur or, if any of them do so, what benefits the Company will derive there from. The forward-looking statements contained in this news release are made as at the date of this news release and the Company does not undertake any obligation to update publicly or to revise any of the forward-looking statements, whether because of new information, future events or otherwise, except as may be required by applicable securities laws. Although the forward-looking statements contained in this news release are based on what management believes are reasonable assumptions, the Company cannot assure investors that actual results will be consistent with them. These forward-looking statements are made as of the date of this news release and are expressly qualified in their entirety by this cautionary statement. Subject to applicable securities laws, the Company does not assume any obligation to update or revise the forward-looking statements contained herein to reflect events or circumstances occurring after the date of this news release.

SOURCE: NextSource Materials Inc.

View the original press release on ACCESS Newswire

News Provided by ACCESS Newswire via QuoteMedia

This post appeared first on investingnews.com